Active Immunization of Patients With Non Small Cell Lung Cancer (NSCLC) Using Fibroblasts Transfected With DNA From Autologous Tumor (Phase IB Study).
Phase of Trial: Phase I
Latest Information Update: 25 Aug 2014
At a glance
- Drugs IC 1001 (Primary)
- Indications Non-small cell lung cancer
- Focus Adverse reactions; Pharmacodynamics
- 16 Aug 2012 Actual initiation date changed from 1 Dec 2011 to 1 Jun 2012 as reported by ClinicalTrials.gov.
- 02 Jun 2012 Trial design presented at the 48th Annual Meeting of the American Society of Clinical Oncology.
- 25 May 2011 Planned End Date changed from 1 Jan 2022 to 1 Jan 2025 as reported by ClinicalTrials.gov.